ERBB2 and cancer: To characterize the abundance of the HER-kinase receptors in primary normal human epidermal keratinocytes (NHEK), protein expression levels for EGFR, HER2 and HER3 were assessed and compared to cancer cell lines of various origins with known HER-kinase receptor expression patterns (Figure 1A).